Cholecystokinin receptor subtypes regulate dopamine D2 receptors in rat neostriatal membranes. Involvement of D1 receptors.
Li
X M
XM
Department of Histology and Neurobiology, Karolinska Institutet, Stockholm, Sweden.
Hedlund
P B
PB
Fuxe
K
K
D000818:Animals; D001058:Apomorphine / Q000031:analogs & derivatives / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism; D015259:Dopamine Agents / Q000378:metabolism; D007700:Kinetics; D017072:Neostriatum / Q000378:metabolism*; D020891:Raclopride; D051381:Rats; D017207:Rats, Sprague-Dawley; D011949:Receptors, Cholecystokinin / Q000145:classification / Q000187:drug effects / Q000502:physiology*; D017447:Receptors, Dopamine D1 / Q000187:drug effects / Q000502:physiology*; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism*; D012457:Salicylamides / Q000378:metabolism*; D012844:Sincalide / Q000494:pharmacology*
D015259:Dopamine Agents; D011949:Receptors, Cholecystokinin; D017447:Receptors, Dopamine D1; D017448:Receptors, Dopamine D2; D012457:Salicylamides; D020891:Raclopride; C009074:N-n-propylnorapomorphine; D012844:Sincalide; D001058:Apomorphine